1. Home
  2. GGRP vs IOBT Comparison

GGRP vs IOBT Comparison

Compare GGRP & IOBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo The Glimpse Group Inc. Common Stock

GGRP

The Glimpse Group Inc. Common Stock

N/A

Current Price

$0.82

Market Cap

11.8M

Sector

Technology

ML Signal

N/A

Logo IO Biotech Inc.

IOBT

IO Biotech Inc.

HOLD

Current Price

$0.04

Market Cap

12.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GGRP
IOBT
Founded
2016
2014
Country
United States
Denmark
Employees
40
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.8M
12.7M
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
GGRP
IOBT
Price
$0.82
$0.04
Analyst Decision
Hold
Analyst Count
0
4
Target Price
N/A
$2.25
AVG Volume (30 Days)
234.6K
186.6M
Earning Date
05-15-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
26.77
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$72.00
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.42
$0.03
52 Week High
$0.92
$2.79

Technical Indicators

Market Signals
Indicator
GGRP
IOBT
Relative Strength Index (RSI) 65.25 25.94
Support Level $0.47 N/A
Resistance Level N/A $0.22
Average True Range (ATR) 0.10 0.02
MACD 0.03 -0.01
Stochastic Oscillator 63.64 15.92

Price Performance

Historical Comparison
GGRP
IOBT

About GGRP The Glimpse Group Inc. Common Stock

The Glimpse Group Inc is a diversified immersive technology platform company, focused on providing enterprise solutions in virtual reality (VR), augmented reality (AR), and spatial computing. The company operates multiple subsidiaries that develop VR and AR software and services across various industries, including corporate training, education, healthcare, government, defense, marketing, retail, and financial services. It also offers AI-driven spatial computing platforms that support simulations, social VR, behavioral health, and corporate events. The Company reports its revenues in three categories: Software Services, Software License and Software-as-a-Service (SaaS), and Royalty Income, with the majority being from the Software Services category.

About IOBT IO Biotech Inc.

IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on T-win technology platform. The product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression.

Share on Social Networks: